Original Research

Surgical Treatment of Nonmelanoma Skin Cancer in Older Adult Veterans

Author and Disclosure Information

 

References

Conclusions

Treatment of NMSC in older adult patients has a low morbidity but needs to be balanced against a patient and family’s goals when the patient presents with life-limiting comorbidities. An elevated 5-year mortality in patients aged > 80 years with serious unrelated medical conditions is intuitive, but this study may help put treatment plans into perspective for families and health care professionals who want to provide an indicated service while maximizing patient quality of life.

Acknowledgments

This manuscript is the result of work supported with resources and the use of facilities at the North Florida/South Georgia Veterans Health System, Gainesville, Florida.

Pages

Recommended Reading

Head and neck tumor grade may predict response to immunotherapy
Federal Practitioner
When too much treatment creates more harm than good
Federal Practitioner
Quality of life benefit exaggerated in some cancer studies
Federal Practitioner
Sociogenomics may explain race disparities in breast cancer mortality
Federal Practitioner
Select patients with breast cancer may skip RT after lumpectomy
Federal Practitioner
High residual liver cancer risk in HCV-cured cirrhosis
Federal Practitioner
Drugging the undruggable
Federal Practitioner
New KRAS inhibitor shows promise in NSCLC
Federal Practitioner
Pregnancy, breastfeeding, and more linked to lower CRC risk
Federal Practitioner
Pembrolizumab for melanoma bittersweet, doctor says
Federal Practitioner